Merck invests in largest specialty gases facility in Hometown, PA.

14 April 2023 | Friday | News

Merck, announced an agreement with the Commonwealth of Pennsylvania to support expansion plans at its semiconductor manufacturing site in Hometown.
Image Source : Public Domain

Image Source : Public Domain

  • Agreement with the Commonwealth of Pennsylvania supports expansion of manufacturing capacities for the semiconductor industry
  • The roughly € 300 million investment is part of the company’s “Level Up” program aimed at accelerating its innovation footprint and production capacities

Merck, a leading science and technology company, today announced an agreement with the Commonwealth of Pennsylvania to support expansion plans at its semiconductor manufacturing site in Hometown. This expansion is part of Merck's Level Up growth program, announced by its Electronics business sector in late 2021, which aims to invest over € 3 billion in innovation and capacity expansion projects by 2025. The roughly € 300 million investment in the Hometown site will further develop the world's largest integrated Specialty Gases facility and support the success of Merck's Semiconductor Solutions business, one of its "Big 3" growth engines. 

“Despite near-term cautions due to the industry’s cyclical nature, the demand for semiconductor materials remains very promising long term,” said Kai Beckmann, Member of the Executive Board of Merck and CEO Electronics. “Having domestic production capacity for critical electronics components has become a high priority for many economies. As the brains of modern electronics, semiconductors enable technology critical to economic growth and global competitiveness. Our expansion plans will support our customers’ investments in the U.S. and boost our overall global footprint of manufacturing facilities around the globe.”

The agreement includes incentive targets associated with at least 68 new jobs and significant potential investments that will enable the company to capture and grow its semiconductor materials business in North America and Europe and provide supplemental capacity to supply Asia.

Level Up program continues to deliver critical global capacity to fuel accelerated semiconductor growth

Driven by accelerated industry growth, Merck is delivering a remarkable track record of investment execution since the introduction of its Level Up growth program and the announcement of significantly more than € 3 billion in innovation and capacities in the U.S., Germany, and Asia by the end of 2025.

As part of this program, the company is significantly investing into R&D and manufacturing capacities in its Electronics U.S. sites, primarily in Arizona, California, Texas, and Pennsylvania. For instance, by the end of the first half of 2023, the company expects to start operations at its new factory in the greater Phoenix, Arizona area for the manufacture of equipment for its Delivery Systems & Services (DS&S) business. The new site will enable the company to further grow its gas and chemical delivery systems business and provide key supplemental capacity to the semiconductor ecosystem.

Last year, Merck successfully executed investments aimed at expanding its semiconductor materials production capacities in Asia. For example, the company opened a new DS&S facility in Kaohsiung, Taiwan, as well as its China Electronics Technology Center and a production facility for organic light-emitting diode (OLED) materials in Shanghai, China. Also in 2022, the company acquired the chemical business of the Korean company Mecaro. Earlier this year, Merck broke ground in a second facility in Kaohsiung, Taiwan, that will produce specialty gases and semiconductor materials for thin film and structuring applications as of 2025.

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close